blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3236934

EP3236934 - PHARMACEUTICAL COMPOSITION, PREPARATION AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.03.2025
Database last updated on 31.03.2026
FormerThe patent has been granted
Status updated on  19.04.2024
FormerGrant of patent is intended
Status updated on  08.02.2024
FormerExamination is in progress
Status updated on  13.07.2018
FormerRequest for examination was made
Status updated on  29.09.2017
FormerThe international publication has been made
Status updated on  20.06.2017
Most recent event   Tooltip18.07.2025Lapse of the patent in a contracting state
New state(s): LU		published on 20.08.2025  [2025/34]
Applicant(s)For all designated states
Nanobiotix
60 rue de Wattignies
75012 Paris / FR
[2024/47]
Former [2020/01]For all designated states
CURADIGM SAS
60 rue de Wattignies
75012 Paris / FR
Former [2017/44]For all designated states
Nanobiotix
60 rue de Wattignies
75012 Paris / FR
Inventor(s)01 / GERMAIN, Matthieu
6 rue de la Fontaine
77163 Dammartin Sur Tigeaux / FR
02 / MEYRE, Marie-Edith
3 Square Nungesser
94160 Saint Mande / FR
03 / POTTIER, Agnès
6 rue Sainte-Beuve
75006 Paris / FR
04 / LEVY, Laurent
246 Boulevard Raspail
75014 Paris / FR
 [2024/21]
Former [2017/44]01 / GERMAIN, Matthieu
3 avenue Marx Dormoy
Entrée 4
94500 Champigny Sur Marne / FR
02 / MEYRE, Marie-Edith
3 Square Nungesser
94160 Saint Mande / FR
03 / POTTIER, Agnès
6 rue Sainte-Beuve
75006 Paris / FR
04 / LEVY, Laurent
246 boulevard Raspail
75014 Paris / FR
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2017/44]
Application number, filing date15798435.224.11.2015
[2017/44]
WO2015EP77425
Priority number, dateEP2014030687525.11.2014         Original published format: EP 14306875
[2017/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016083333
Date:02.06.2016
Language:EN
[2016/22]
Type: A1 Application with search report 
No.:EP3236934
Date:01.11.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2016 takes the place of the publication of the European patent application.
[2017/44]
Type: B1 Patent specification 
No.:EP3236934
Date:22.05.2024
Language:EN
[2024/21]
Search report(s)International search report - published on:EP02.06.2016
ClassificationIPC:A61K9/00, A61K51/12, A61K47/50, A61K9/127, A61K41/00, A61K31/704, A61K47/69, A61P35/00
[2024/10]
CPC:
A61K9/1271 (EP,IL,US); A61K9/127 (EP,CN,IL,KR,US); A61K9/00 (CN,IL);
A61K31/704 (EP,IL,US); A61K47/6911 (EP,IL,KR,US); A61K47/6929 (IL,KR);
A61K9/0009 (EP,IL,KR,US); A61K9/0019 (EP,IL,US); A61K9/51 (IL,KR,US);
A61P35/00 (EP,IL); B82Y5/00 (CN,IL) (-)
Former IPC [2017/44]A61K9/00, A61K41/00, A61K9/127, A61K47/50, A61K51/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/44]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG, HERSTELLUNG UND VERWENDUNGEN DAVON[2017/44]
English:PHARMACEUTICAL COMPOSITION, PREPARATION AND USES THEREOF[2017/44]
French:COMPOSITION PHARMACEUTIQUE, SA PRÉPARATION ET SES UTILISATIONS[2017/44]
Entry into regional phase19.06.2017National basic fee paid 
19.06.2017Designation fee(s) paid 
19.06.2017Examination fee paid 
Examination procedure19.06.2017Amendment by applicant (claims and/or description)
19.06.2017Examination requested  [2017/44]
19.06.2017Date on which the examining division has become responsible
12.07.2018Despatch of a communication from the examining division (Time limit: M04)
05.11.2018Reply to a communication from the examining division
20.12.2018Despatch of a communication from the examining division (Time limit: M04)
09.04.2019Reply to a communication from the examining division
31.03.2020Despatch of a communication from the examining division (Time limit: M04)
16.07.2020Reply to a communication from the examining division
24.11.2020Despatch of a communication from the examining division (Time limit: M04)
11.12.2020Reply to a communication from the examining division
04.05.2021Despatch of a communication from the examining division (Time limit: M06)
25.10.2021Reply to a communication from the examining division
12.09.2023Despatch of a communication from the examining division (Time limit: M04)
28.09.2023Reply to a communication from the examining division
09.02.2024Communication of intention to grant the patent
11.04.2024Fee for grant paid
11.04.2024Fee for publishing/printing paid
11.04.2024Receipt of the translation of the claim(s)
Divisional application(s)EP24176220.2  / EP4431155
Opposition(s)25.02.2025No opposition filed within time limit [2025/18]
Fees paidRenewal fee
13.11.2017Renewal fee patent year 03
12.11.2018Renewal fee patent year 04
26.11.2019Renewal fee patent year 05
23.11.2020Renewal fee patent year 06
12.11.2021Renewal fee patent year 07
24.11.2022Renewal fee patent year 08
07.11.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG22.05.2024
EE22.05.2024
HR22.05.2024
IT22.05.2024
LV22.05.2024
MC22.05.2024
SI22.05.2024
SK22.05.2024
SM22.05.2024
RS22.08.2024
IS22.09.2024
LU24.11.2024
[2025/34]
Former [2025/33]BG22.05.2024
EE22.05.2024
HR22.05.2024
IT22.05.2024
LV22.05.2024
MC22.05.2024
SI22.05.2024
SK22.05.2024
SM22.05.2024
RS22.08.2024
IS22.09.2024
Former [2025/22]BG22.05.2024
EE22.05.2024
HR22.05.2024
IT22.05.2024
LV22.05.2024
SI22.05.2024
SK22.05.2024
SM22.05.2024
RS22.08.2024
IS22.09.2024
Former [2025/11]BG22.05.2024
EE22.05.2024
HR22.05.2024
IT22.05.2024
LV22.05.2024
SK22.05.2024
SM22.05.2024
RS22.08.2024
IS22.09.2024
Former [2025/10]BG22.05.2024
EE22.05.2024
HR22.05.2024
LV22.05.2024
SK22.05.2024
SM22.05.2024
RS22.08.2024
IS22.09.2024
Former [2025/09]BG22.05.2024
EE22.05.2024
HR22.05.2024
LV22.05.2024
RS22.08.2024
IS22.09.2024
Former [2024/49]BG22.05.2024
HR22.05.2024
LV22.05.2024
RS22.08.2024
IS22.09.2024
Former [2024/46]BG22.05.2024
HR22.05.2024
IS22.09.2024
Cited inInternational search[XI] WO2005063305  (BRACCO RESEARCH SA et al.)
 [XI] EP2000150  (TOTO LTD et al.)
 [XI] WO2012104277  (NANOBIOTIX et al.)
 [XI] WO2012104275  (NANOBIOTIX et al.)
 [XI] WO2014057432   [X] 1-4,8,13,16,17,20 * paragraphs [0005] , [0009] , [0025] - [0028] - [0043] , [0067] , [0068]; claims 1,9,10 *[I] 1-20
 [XI]   HE C ET AL: "Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 31, no. 13, 1 May 2010 (2010-05-01), pages 3657 - 3666, XP026946003, ISSN: 0142-9612, [retrieved on 20100206], DOI: 10.1016/J.BIOMATERIALS.2010.01.065

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2010.01.065
 [XI]   "NCL Method PCC-2 Measuring Zeta Potential of Nanoparticles", 1 November 2009 (2009-11-01), XP055171529, Retrieved from the Internet [retrieved on 20150223] [I] 1-20
by applicantWO2005063305
   JAIN K.R.; STYLIANOPOULOS T: "Delivering nanomedicine to solid tumors", NATURE REVIEWS. CLINICAL ONCOLOGY, vol. 7, 2010, pages 653 - 664
   TORCHILIN V.P.: "Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery", NATURE REVIEWS. DRUG DISCOVERY, vol. 13, 2014, pages 813 - 827
   D. LORUSSO ET AL.: "Annals of Oncology", vol. 18, 2007, article "Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome", pages: 1159 - 1164
   "International Standard IS022412 Particle Size Analysis", DYNAMIC LIGHT SCATTERING, INTERNATIONAL ORGANISATION FOR STANDARDISATION (ISO, 2008
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.